Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
about
Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDsTramadol Extended-Release for the Management of Pain due to OsteoarthritisProton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control studyBuilding a better aspirin: gaseous solutions to a century-old problemDrug-induced side effects affecting the gastrointestinal tractClinical trial data in support of changing guidelines in osteoarthritis treatment.Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiotaManagement of chronic knee pain: a survey of patient preferences and treatment receivedDecreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.Rationally designed multitarget agents against inflammation and pain.Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes.Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project)Estimates of benefits and harms of prophylactic use of aspirin in the general population.Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis.Efficacy and safety of diclofenac diethylamine 1.16% gel in acute neck pain: a randomized, double-blind, placebo-controlled studyDiclofenac sodium topical solution with dimethyl sulfoxide, a viable alternative to oral nonsteroidal anti-inflammatories in osteoarthritis: review of current evidence.The effects of a non-operative multimodal programme on osteoarthritis of the kneeTopical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients.Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients.Dyspepsia and Helicobacter pylori.The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi ArabiaUse of nicorandil is Associated with Increased Risk for Gastrointestinal Ulceration and Perforation- A Nationally Representative Population-based study.Clinical trial: comparison of ibuprofen-phosphatidylcholine and ibuprofen on the gastrointestinal safety and analgesic efficacy in osteoarthritic patients.Duloxetine in the management of chronic musculoskeletal painComparison of the Effects on Rib Fracture between the Traditional Japanese Medicine Jidabokuippo and Nonsteroidal Anti-Inflammatory Drugs: A Randomized Controlled Trial.Single- and multiple-dose pharmacokinetics of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) compared with immediate-release hydrocodone bitartrate/ibuprofen and immediate-release tramadol HCl/acetaminopheNSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes.Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary careEsomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers.Clinical pharmacology of celecoxib, a COX-2 selective inhibitor.Developing a Web-Based Version of An Exercise-Based Rehabilitation Program for People With Chronic Knee and Hip Pain: A Mixed Methods Study.Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary careClinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial.Management of chronic nonmalignant pain with nonsteroidal antiinflammatory drugs. Joint opinion statement of the Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical Pharmacy.Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain.Review of the cardiovascular safety of COXIBs compared to NSAIDS.Patient perspectives of dabigatran: analysis of online discussion forums.Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.
P2860
Q22306448-F9E574A1-5A36-4746-ADAB-B9F077E86ED4Q26800279-44DA35C0-A8C7-44C8-8781-46FFF04234D2Q27015822-21B54B1B-01F2-43A4-BE96-6E35CD0215BAQ28211313-CEFF208C-AA1D-433B-9EE1-2AC56A892FD7Q28218664-7321B0D9-4B51-4487-87ED-D4B79AA96BD2Q28219073-786CDF98-3F16-4441-8316-9D8FDAD20577Q30804806-98873639-3975-480A-AC94-A7E04D68F303Q33259369-6BB51C42-B436-4C62-80B8-5BDB18A07954Q33370398-AD9CCB41-4E30-4678-9370-66DC4B4BF1F1Q33432343-6BFB0750-7719-47F4-A8D2-7C1B4A8B2D54Q33960685-FA3E6B7A-CCF9-47CB-B87C-5635638DB804Q34134282-A614CB33-4426-4781-84C3-FDAD07C8C456Q34174937-5340D85C-DEC6-4862-A185-5DDE5B0300E2Q34310573-65382240-B70B-47C8-88A3-53E391686448Q34432503-188875F6-20E9-4182-9340-DE30C2105D20Q34449825-E37FF681-25C8-400B-BB96-2B57F542B083Q34960543-D8F999EF-3ABF-42E2-93D6-AEB3B69C16BBQ35122695-6A659F39-0129-45DA-9466-A592536200CEQ35240233-CB744FB7-BDE9-4AEE-A34D-3AEB5803EA00Q35526741-0532DDAD-A7DC-46A2-8A94-3CA07F03116FQ35551302-8882C283-00D7-43E4-B8E8-29D60F7A9453Q35573791-5C1E9397-C0C5-4A6C-99C7-3E12048F4045Q35743672-AE116059-6FCE-47C0-9628-272FEA567989Q35791249-7DDF8769-8A6E-4DB1-AF57-9DC00D3C98BAQ35964230-B6B1693F-BAB4-4599-BE3E-14D7A973AFA6Q36071024-6A274965-092A-45F5-88EC-52CD5FC21CD5Q36132182-8131459F-2DC0-4488-AF0F-35646E4A44F2Q36137313-FEC76D6A-A6A5-4741-9C5B-C66B277FA1ACQ36666966-89EC94F8-9A9F-4559-8633-1992F806AA77Q36753481-9124061B-0C0C-42CF-B6A2-A8A3CD84E9CCQ36808048-AA594E23-A99C-4D9E-A1E8-94B03E6E8B4CQ36904910-730317AC-D22A-4776-8527-587AB1BDCEDAQ36964571-E2E9EF4D-65EE-48EF-9A93-63F679A83604Q37101613-6A848DBF-1D88-4E59-B10F-2CD768AA8344Q37169645-2EAB6565-A206-4C3D-B958-D1B81E5EB05DQ37173212-7D8DFE27-E054-482C-A0C1-F4FB76DD94C0Q37173856-1372B89C-E9AD-4C57-AC33-C469A56DF9A6Q37178937-7B3154A7-4B1A-4805-8C78-9B2BE6DFA974Q37268085-EA2033EF-609D-4C77-A2E7-FEDFD8CB5F24Q37272199-52018B56-4D4F-4654-AE33-44640F661A8C
P2860
Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk of adverse gastrointestin ...... nested case-control analysis.
@ast
Risk of adverse gastrointestin ...... nested case-control analysis.
@en
Risk of adverse gastrointestin ...... nested case-control analysis.
@nl
type
label
Risk of adverse gastrointestin ...... nested case-control analysis.
@ast
Risk of adverse gastrointestin ...... nested case-control analysis.
@en
Risk of adverse gastrointestin ...... nested case-control analysis.
@nl
prefLabel
Risk of adverse gastrointestin ...... nested case-control analysis.
@ast
Risk of adverse gastrointestin ...... nested case-control analysis.
@en
Risk of adverse gastrointestin ...... nested case-control analysis.
@nl
P2860
P1433
P1476
Risk of adverse gastrointestin ...... nested case-control analysis.
@en
P2093
Richard Logan
P2860
P304
P356
10.1136/BMJ.331.7528.1310
P407
P577
2005-12-01T00:00:00Z